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ABSTRACT
This study reviewed the occurrence of chondroitin sulfate (CS) motifs 4-C-3, 7-D-4, and 3-B-3(-),
which are expressed by progenitor cells in tissues undergoing morphogenesis. These motifs have
a transient early expression pattern during tissue development and also appear in mature tis-
sues during pathological remodeling and attempted repair processes by activated adult stem
cells. The CS motifs are information and recognition modules, which may regulate cellular behav-
ior and delineate stem cell niches in developmental tissues. One of the difﬁculties in determining
the precise role of stem cells in tissue development and repair processes is their short engraft-
ment period and the lack of speciﬁc markers, which differentiate the activated stem cell lineages
from the resident cells. The CS sulfation motifs 7-D-4, 4-C-3, and 3-B-3 (-) decorate cell surface
proteoglycans on activated stem/progenitor cells and appear to identify these cells in transi-
tional areas of tissue development and in tissue repair and may be applicable to determining a
more precise role for stem cells in tissue morphogenesis. STEM CELLS 2018;00:1–12
SIGNIFICANCE STATEMENT
Interest in stem cells and their therapeutic potential has exploded in recent years. Elucidation
of the complexity of the carbohydrate components of the stem cell surface has yielded impor-
tant information on their differentiation status and identiﬁed those cells committed to a plurip-
otent state. Activated stem cells differentiate along speciﬁc differentiation pathways into
speciﬁc cell lineages. This is reﬂected in their cell surface glycodynamics and can be monitored
using speciﬁc monoclonal antibodies which identify the 4C3, 7D4 and 3B3(-) sulfation motifs on
cell surface chondroitin sulfate proteoglycans. These are also useful to monitor tissue morpho-
genetic changes in development and tissue repair.
INTRODUCTION
This article reviews the chondroitin sulfate
(CS) sulfation motifs identiﬁed by monoclonal
antibodies (mAbs) 4-C-3, 7-D-4, and 3-B-3 (-),
which decorate proteoglycans associated with
stem/progenitor cell populations in tissue
development and in pathological remodeling.
The CS Sulfation Motif Presentations
CS is a glycosaminoglycan (GAG), which is com-
posed of β1-3 and β 1-4 glycosidically linked
D-glucuronic acid and N-acetyl galactosamine
O-sulfated at the 2, 4, and C6 positions in a
repeat disaccharide [1,2]. The D-glucuronic acid
moiety of CS may be epimerized to α L-iduronic
acid in the related GAG dermatan sulfate (DS).
This leads to a considerable degree of structural
diversity in CS/DS with more than 1,000 penta-
saccharide sequences possible, which can explore
a varied number of interactive structural confor-
mations [1,2]. This large array of structures
explains why these CS motifs interact with such
a diverse repertoire of cytokines, chemokine’s,
morphogens, and growth factors, which regulate
cellular differentiation and proliferation during
tissue development [1–5]. The 3-B-3 (−), 6-C-3,
7-D-4, and 4-C-3 CS sulfation motifs in CS chains
are depicted in Figure 1. These were identiﬁed in
intact native CS chains and following partial
depolymerization using chondroitinase ABC
(Fig. 1A, 1B) [1]. Complete enzymatic digestion of
the CS chain using chondroitinase ABC generates
unsaturated 3-B-3 (+) and 2-B-6 (+) stub disac-
charide epitopes (Fig. 1C). These should not be
confused with the 3-B-3 (−) and 2-B-6 (−)
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epitopes, which are terminal epitopes generated by hyaluroni-
dase (HYAL 4) (Fig. 1D).
The mast cell proteoglycans serglycin and perlecan have
been reported to display a 2-B-6 (−) epitope on their CS chains
[6]. In similar to 3-B-3 (−), 2-B-6 (−) is not generated by chon-
droitinase ABC digestion. The 2-B-6 (−) epitope has previously
been reported in osteoarthritic cartilage [7]. Generation of this
epitope is due to the action of a member of the HYAL family,
HYAL-1 or HYAL-4, which are CS hydrolases cleaving CS in the
β1 ! 4 disaccharide glycosidic linkage [8]. In addition to the
generation of the 2-B-6(−) epitope in chondroitin-4-sulfate, this
enzyme may also act on chondroitin-6-sulfate chains to gener-
ate the 3-B-3 (−) CS epitope. The 2-B-6 (−) and 3-B-3(−) epi-
topes and the production of HYAL-4 by mast cells are
associated with tissue development and with connective tissue
remodeling in inﬂammatory conditions. The ﬁndings of this
study also suggest that like mast cells, chondroprogenitor cells
may express HYAL-4 and thus generate the 3-B-3(−) epitope;
however, this may be attached to a different proteoglycan to
that found in mast cells.
Raising of CS Sulfation Motif Antibodies and
Identiﬁcation of the Epitopes They Identify in
Connective Tissues
In the early 1980’s, a range of anti-CS mAbs were developed
and shown to recognize speciﬁc sulfation motif epitopes in cell
and matrix GAGs . Initial expectations were that mAbs against
GAG epitopes would be extremely difﬁcult to raise as these
Figure 1. (A): CS sulfation motif organization in a CS chain showing the terminal 3-B-3 (−) motif and 6-C-3 motifs. (B): The 7-D-4 and
4-C-3 motifs have been mapped by partial digestion of CS chains by chondroitinase ABC. (C): A terminal unsaturated 3-B-3(+) stub epitope
is also generated when the CS chain undergoes complete digestion with chondroitinase ABC. (D): HYAL4 generates the 2-B-6(−) and 3-B-3
(−) epitopes.
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represent highly conserved structures occurring throughout
invertebrate and vertebrate evolution more than hundreds of
millions of years. However, with the use of a hyperimmuniza-
tion protocol and draining lymph nodes as the source of lym-
phocytes for hybridoma production, a large number of mAbs
recognizing highly conserved protein and carbohydrate epi-
topes on macromolecules were developed and shown to be
applicable to the investigation of a wide variety of animal spe-
cies [9–11]. These mAbs recognized different CS isomer neoe-
pitopes and native CS GAG chains [1,9,11–13]. Then, two of
these new mAbs (6-C-3 and 7-D-4) were used in immunohisto-
chemical studies examining the location of different CS-
proteoglycans in developing Bursae of Fabricius isolated from
embryonic chickens [9]. This study clearly demonstrated differ-
ential staining patterns of CS sulfation motifs on cell surface
and matrix proteoglycans during embryonic chick lymphopoi-
esis. Retrospectively, and more recently, analysis of this data
suggested that these differential staining patterns were pre-
sent on different stem, progenitor, and stromal cells undergo-
ing different stages of lymphopoiesis in the developing Bursa.
Use of CS-Sulfation Motif Antibodies in
Immunolocalization Studies
The development of mAbs to speciﬁc CS sulfation motifs
(Fig. 1, Table 1) has facilitated the identiﬁcation/immunolocali-
zation of speciﬁc subsets of cells that reside in morphological
zones, where stem/progenitor cells are found in musculoskele-
tal tissues including articular cartilage, tendons, and interver-
tebral disc (IVD) (Fig. 2A–2D). These mAbs also identify subsets
of cells in morphological zones from several other tissues
where stem/progenitor cells reside; that is, the crypts of the
gut villae (mouse) and the limbus at the interface of the cor-
nea and the sclera in the developing chick eye, and subsets of
cellular zones in the developing chick bursa where hematopoi-
esis and lymphopoiesis occur [1,9–12], the hair follicle and skin
(Fig. 2E, 2G)). CS sulfation motifs occur at many important cen-
ters/interfaces of growth and differentiation in the develop-
ment of a wide range of connective tissues. During embryonic
development of the IVD of the rat spine, the CS motif recog-
nized by mAb 7-D-4 is associated with cells of the transitional
growth tissue that occurs between the inner and outer annu-
lus, which acts as a physis in the IVD [14]. Furthermore, the
GAG epitope recognized by mAb 3-B-3 (−) is associated with a
speciﬁc subpopulation of cells surrounding the developing
nucleus pulposus (Fig. 2H). CS sulfation motifs 3-B-3 (−), 7-D-4,
4-C-3, and 6-C-3 are also differentially expressed in developing
tendon; limbus; skin, gut, and articular cartilage, all occurring
at important sites of tissue differentiation and growth/
renewal. In articular cartilage, the differential distribution of
these CS sulfation motifs is, however, particularly intriguing
(Figs. 3C, 3G). Here, 3-B-3 (−), 7-D-4, and 4-C-3, are associated
with speciﬁc subpopulations of chondrocytes within the super-
ﬁcial zone of the tissue following joint cavitation: 3-B-3(−) is
expressed by a small subset of chondrocytes at the surface;
7-D-4 is expressed by all superﬁcial zone cells to a depth of
2–3 cells; and 4-C-3 reactivity is more widespread, extending
to a slightly greater depth within the tissue. This zone not only
contains a chondroprogenitor cell population, but growth fac-
tors of the TGF-β and IGF families are also sequestered here
during development [17–19]. Discrete small niches are also
surrounded by perlecan in the surface regions of hip, knee,
and elbow cartilage rudiments (Fig. 3H) [20] and also in a peri-
chondrial region of the elbow (Fig. 3F). Similar stem cell niches
have also been demonstrated in the outer AF-vertebral growth
plate margins in a number of species [21] and in peripheral
regions of the nucleus pulposus (NP) in the developmental rat
IVD (Fig. 2A, 2C)) [22]. Perlecan associated with such niches
has been shown to be a hybrid proteoglycan substituted with
HS and the 7-D-4 CS motif [21]. Immunolocalization of perle-
can in human fetal knee and hip cartilage is a useful technique
to delineate the stem cell niches where the progenitor cells
reside in the surface regions of these cartilages (Fig. 3H, 3K)).
Recently, cell nests have been identiﬁed in adult ovine IVD tis-
sues and shown to be surrounded by a dense layer of hyaluro-
nan (HA). HA has also been described surrounding stem cell
niches where it has a role in the maintenance of stem cells in
a quiescent state of self-renewal [23,24]. Similar cell nests
have also been identiﬁed in adult human IVDs [25], isolated,
cultured, and shown to express 4-C-3, 7-D-4, and 3-B-3(−) CS
sulfation motifs and a number of stem cell CD markers by ﬂow
cytometry . These represent adult stem cell niches in the IVD.
Such cell nests also occur in grade IV degenerate human IVDs
and in an ovine model of experimental disc degeneration [25].
Evidence of Stem/Progenitor Cells Within the Surface
Regions of the Cartilaginous Rudiments of Diarthrodial
Joints
Numerous studies have demonstrated the presence of stem/
progenitor cell subpopulations within the surface regions of
articular cartilage of diarthroidal joints [18,26–28]. These cells
have been shown to retain their chondrogenic potential during
extended monolayer culture and exhibit phenotypic plasticity
in their differentiation pathway, thus may have signiﬁcant
potential in cell-based articular cartilage repair therapies. Our
studies show that primary chondrocytes from full depth imma-
ture bovine articular cartilage are capable of recapitulating a
zonally organized neocartilage tissue when grown in vitro on
MilliPore ﬁlter membranes (MilliporeSigma, Billerica, MA)
(Fig. 4A, 4B) [29]. The matrix composition and organization of
this tissue are strikingly similar to developmentally immature
articular cartilage in vivo. Neocartilages produced more than
an 8 week culture period have prominent surface expression
of type I collagen (Fig. 4C) with type II collagen and aggrecan
throughout the cartilage depth (Fig. 4C). No expression of ver-
sican is observed, but decorin, biglycan, and lubricin occur in
the surface region (Fig. 4C). Chondroitin-0-sulfate and C-4-S
are also prominent CS isomers (Fig. 4C) but not chondroitin-6-
sulfate (C-6-S), keratan sulfate (KS), or dermatan sulfate (DS)
(Fig. 4C). These ﬁndings are typical of an immature cartilage,
which does not contain appreciable levels of C-6-S, KS, and DS,
which appear later with tissue maturation (Fig. 4B). Chondro-
cytes enriched from the superﬁcial zone of articular cartilage
generate similar zonally organized neocartilage when grown
under identical culture conditions; however, cells enriched
from mid or deep zone appear considerably less effective in
this regard [30]. Similar zone-speciﬁc, maturational differences
of different chondrocyte subpopulations grown in vitro have
been noted by other groups [31,32]. This data suggest that
superﬁcial zone cells have a greater developmental repertoire
than cells in subjacent tissue zones, consistent with apposi-
tional growth being driven by a stem/progenitor cell subpopu-
lation resident within the superﬁcial zone of the native tissue
©2018 The Authors Stem Cells published by
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[18,33]. The observation that CS sulfation motifs are strongly
associated with chondrocytes of the superﬁcial zone of the
native tissue suggests that these unique sulfation motifs may
be associated with the distinct cell phenotypes involved in the
initial stages of the chondrocyte differentiation pathway
[17,18,29,34,35] (i.e., stem–progenitor—transit-amplifying unit
cell). Indeed, we have observed a high degree of similarity in
the labeling patterns of both aggrecan and perlecan with mAb
4C3 suggesting that there may be CS substitution, and hence
functional modiﬁcation, of both aggrecan and perlecan in this
superﬁcial zone [19]. The perlecan knockout mouse shows con-
siderable cartilage pathology [36], and perlecan has well-
established roles in cartilage matrix stabilization and chondro-
genesis supporting this hypothesis [37,38]. Perlecan is a hybrid
HS-CS-proteoglycan in articular cartilage, and in the growth plate
contains 4,6 disulfated CS-E motifs that direct collagen ﬁbrillogen-
esis [39].
FGF-18 Promotes Early Chondrogenesis and
Maturational Osteogenic Differentiation of Bone
Marrow Stromal Stem Cells
In a recent study using bone marrow stromal stem cells, FGF-18
was shown to stimulate these cells along a chondrogenic differ-
entiation pathway [40]. FGF-18 initially promoted chondroblasts
Figure 2. (A), (B), (C) Immunoperoxidase localisation of CS sulphation motif epitopes 3B3(-), 7D4 and 4-C-3, respectively, in a lumbar rat
intervertebral disc at E19. (D), (F) Immunoﬂuorescence localisation of 7D4 and 3B3(-)in transitional tissues of the lumbar rat E19 disc.
(E), (F), (G) Immunoperoxidase localisation of 3B3(-), 7D4 and 4-C-3 in 14 week old gestational age human foetal skin. Note differential
staining of CS motifs around hair follicles. (I), (J) Immunoﬂuorescence localisation of perlecan (green) and the 7D4 CS sulphation motif
epitope (red) in human paraspinal blood vessels at 14 week gestational age (DAPI counterstained nuclei shown in blue). Scalebars in
microns. Figure segments (A–C) reproduced from reference [14], (D–E) from reference [22] and (E–G, I, J) from [15] with permission. Fig-
ure segments (I) and (J) were originally published in The Biochemical Journal. Hayes A, Sugahara K, Farrugia B, Whitelock JM, Caterson B,
Melrose J. Biodiversity of CS-proteoglycan sulfation motifs: chemical messenger recognition modules with roles in information transfer,
control of cellular behaviour and tissue morphogenesis 20186 475 [3]:587–620 © copyright Biochemical Society.
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to a committed chondrocytic phenotype and later stimulated
chondrocyte maturational changes toward an osteogenic phe-
notype [40]. Decorin and biglycan were signiﬁcantly upregu-
lated by the FGF-18 treatment (Fig. 5D, 5E, 5J) and shown to be
immunolocalized in the micro mass cell pellets in the same
region where calcium deposition occurred (Fig. 5I, 5K). Consis-
tent with our earlier ﬁndings with FGF-18, some of the chondro-
progenitor cells expressed the 4-C-3 and 7-D-4 CS sulfation
motifs and these were also located in the same regions of the
pellet where calcium deposition occurred (Fig. 5G, 5H). Thus,
©2018 The Authors Stem Cells published by
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FGF-18 promoted sequential chondrogenic commitment and an
osteogenic phenotype in the stromal stem cells.
CS Sulfation Motifs as Molecular Markers of Cell
Signaling in Tissue Morphogenesis
GAG chains store and transfer information to cells providing
molecular recognition and activity signals, which modulate cell
growth and development by regulating growth factors such as
the FGF family, Hedgehog, Wingless, and the Semaphorins
[42,43]. Much progress has been made in recent years in our
understanding of the contribution of GAGs to tissue develop-
ment in health and ECM remodeling in disease processes. A
number of publications on CS have demonstrated that these
have important roles in health and disease [1,5]. Virtually,
every cell produces GAGs, which are incorporated into a cell
associated glycocalyx, their interactive partners and the biolog-
ical processes they affect are all areas of importance in tissue
development and in repair processes in tensional and weight
bearing connective tissues [44]. A greater understanding of
these processes may improve tissue regeneration strategies.
Gaining this knowledge will also provide the scientiﬁc research
community with new insights as to how the pericellular envi-
ronment surrounding stem/progenitor cells may regulate their
senescence and subsequent activation to proliferate and differ-
entiate into more mature cell populations during tissue growth
and development and in tissue repair.
Aggrecan is the major CS-substituted proteoglycan of carti-
laginous tissues, with well-known extracellular matrix stabiliz-
ing, space-ﬁlling, and water imbibing properties that equip
these tissues with dynamic resilience to compressive loading
[44]. Correct sulfation of CS-proteoglycans is essential for
proper Indian hedgehog signaling in the developing growth
plate [45], perlecan, a hybrid CS-HS proteoglycan in cartilage is
also responsible for the localization and activity of the related
Sonic hedgehog protein [46]. Native CS sulfation motifs such
as 7-D-4, 4-C-3, and 3-B-3(−) on proteoglycans may serve to
immobilize growth factors/morphogens actively involved in
hematopoiesis, skin morphogenesis, chondrogenesis, and IVD
development [1,14,18,21]. The unique distributions of native
CS sulfation motifs with surface zone progenitor cells in articu-
lar cartilage [18,35] and strategically located within the devel-
opmental IVD [14] and human fetal elbow [16] suggests that
these identify an early stage of progenitor cell differentia-
tion [14,18].
Identiﬁcation of Embryonic Stem Cells
Murine and human embryonic stem cell markers have been
extensively documented [47,48] and used in the determination
of their pluripotent state [49,50] and in the characterization of
speciﬁc progenitor cell populations from a number of tissues
[40,51–60]. Surface stem cell markers have also facilitated the
isolation of speciﬁc stem cell populations [48–51,61–63]. Cell
surface markers identiﬁed by mAbs (GCTM-2, TRA-1-60, TRA-
1-81, TG343, and PHM-5) also have important roles to play in
the identiﬁcation of differentiation dependent post-
translational changes in cell surface carbohydrate epitopes in
pluripotent stem cells, which demonstrate cell lineage commit-
ment and have been used in the staging of MSC maturation
[49]. PMH-5 is a monoclonal antibody that identiﬁes a 140 kDa
glomerular epithelial surface coat sialoglycoprotein present in
the glycocalyx of podocytes, which was called as podocalyx-
cin [64].
Antibodies to GCTM-2, TRA-1-60, TRA-1-81, and TG343 iden-
tify a cell surface KS-proteoglycan with TRA-1-60 and TRA-1-81
identifying a KS side chain epitope, whereas GCTM-2 and TG343
identify core protein epitopes. PHM-5 identiﬁes the transmem-
brane proteoglycan podocalyxcin and SSEA-3 and SSEA-4 identify
a carbohydrate epitope in a cell surface glycolipid [48]. Subse-
quent studies showed that TRA-1-60 and TRA-1-81 identiﬁed the
KS chains of podocalyxcin, [65] whereas GCTM-2 identiﬁed podo-
calyxcin core protein. Precise elucidation of the TRA-1-60 and
TRA-1-81 GAG-binding epitope by screening against a 500 GAG
oligosaccharide micro-array showed that the lactosamine oligo-
saccharide Galβ1-3GlcNAcβ1-3Galβ1-4GlcNAc was the minimal
epitope identiﬁed by this antibody, which is a core component of
KS [66].
Stem Cell Surface Carbohydrate and Protein Expression
The Cadherin System. The cadherin, calcium-dependent type-
1 transmembrane proteins form adherens junctions, binding
cells tightly together within tissues and have essential roles to
play during embryonic development and are critical in the
induction of stem cell pluripotency [67]. Cell adhesion is medi-
ated by extracellular cadherin domains, whereas intracellular
cytoplasmic domains are associated with a large number of
adaptor and cytoskeletal signaling proteins constituting the
cadherin adhesome. The cadherin membrane-spanning adhe-
rens junction proteins have crucial roles in cell–cell contact for-
mation and are connected to cytoplasmic proteins, which
Figure 3. (A) Confocal ﬂuorescence image of a 14 week-old gestational age human fetal elbow depicting perichondrial perlecan labelling
(green) immunolocalized with a perlecan domain IV mAb (A7L6). The localization of the A7L6 primary antibody was visualized using a
Fluorescein isothiocyanate (FITC)-labeled secondary antibody, cell nuclei were counterstained with DAPI (blue). Bottom left inset shows
the whole elbow joint after toluidine blue staining for total sulphated proteoglycan. Boxed area in bottom right of micrograph shows peri-
chondrial region examined at higher magniﬁcation in B (inset, top right). (B) perlecan labelling delineates putative stem cell niches in high
power magniﬁcation of perichondrial region. Figure reproduced from [16] with permission. (C) Confocal ﬂuorescence image shows that
labelling of the 7-D-4 CS sulfation motif is also associated with transitional perichondrial tissues (green labelling). The area in (C) is
depicted at higher magniﬁcation in (D). The 7-D-4 epitope was visualized using a FITC-labeled secondary antibody. Cell nuclei were coun-
terstained with propidium iodide (red). Figure reproduced from [16] with permission. (E), (F), (G) Confocal ﬂuorescence images showing
labeling of the 4-C-3 CS sulfation motif epitope in the surface regions of the developmental elbow (E, G) and perichondrium (F). Boxed
area in (E) shown at higher magniﬁcation in (G). The 4-C-3 epitope was visualized using a FITC-labeled secondary antibody, cell nuclei
were counterstained with propidium iodide (red). Figure reproduced from [16] with permission. (H), (I), (J) Immunolocalization of perle-
can in tibial cartilage from a 14 week-old human fetal hip (H), (I) and knee (J), (K) delineating small discrete groups of cells in stem cell
niches within the rudiments. The cellular morphologies in the stromal tissue associated with the rudiment surface regions (L) and within
the rudiment proper (M) differed markedly in non-stained Nomarsky DIC images. Figure modiﬁed from [100] with permission. Perlecan
immunolocalization using a domain IV perlecan antibody (mAb A7L6) and alkaline phosphatase-labelled secondary antibody using
NovaRED for visualization.
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regulate signaling pathways and relay information regarding
cell interactions to the nucleus [68–70]. E-cadherin controls
early differentiation of stem cells and the regulation of
pluripotency. Undifferentiated embryonic stem cells express
high levels of E-cadherin and OCT-4; however, these are lost
when the cells differentiate and a switch to N-cadherin
Figure 4. (A): Composite ﬁgure showing immunoﬂuorescent labeling patterns of the CS sulfation motifs 3-B-3(−), 7-D-4, and 4-C-3 in
the superﬁcial and deep regions of juvenile bovine knee articular cartilage. A stem cell progenitor cell population is present in the
surface regions of developing cartilage rudiments [17,18]. (B): Neocartilages grown on Millipore ﬁlter membranes (6 × 106 cells/
insert) following 2, 4, 6, and 8 weeks culture. The increase in neocartilage thickness over the culture period is shown in the Alcian
blue-stained bright-ﬁeld images. Immunoﬂuorescent localizations of collagen types I and II, aggrecan and versican, biglycan, decorin
and lubricin shows that the neocartilage has a similar composition and organization to mature articular cartilage (C). The neocartilage
was particularly rich in C-0-S and C-4-S, which is typical of an immature cartilage, but contained little C-6-S, KS, and DS, which are
associated with maturational stages of cartilage development. Figure modiﬁed from Hayes AJ, Hall A, Brown L, Tubo R, Caterson
B. Macromolecular organization and in-vitro growth characteristics of scaffold-free neocartilage grafts. J Histochem Cytochem.
2007;55 [8]:853–66. DOI: 10.1369/jhc.7A7210.2007 with permission SAGE publishers.
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synthesis occurs. Embryonic stem cells expressing the stem-cell
marker, stage-speciﬁc embryonic antigen-1 (SSEA1) also express
E-cadherin but not N-cadherin; however when they undergo
differentiation, the expression of SSEA-1 and E-cadherin is lost
but the expression of N-cadherin appears. E-cadherin maintains
the compact features of stem cell colonies. Interaction of ECM
components with E-cadherin can cause morphological changes
in stem cells and promote their differentiation.
Stem Cell Surface Carbohydrate Epitopes
As already indicated, niche stem cells are normally maintained
in an aggregated compact form by cell surface proteins such
as E-cadherin. However, quiescent embryonic stem cells also
express characteristic carbohydrate cell surface markers such
as SSEA-1, epithelial membrane core mucin antigen (ECMA)-1
and 2, TRA 1–60 and TRA-1-81 (tissue rejection antigen and
Trafalgar antigen), and GCTM-2, which identify components of
the large CS and KS substituted transmembrane cell surface
proteoglycan podocalyxcin [71,72]. When activated, stem cells
undergo differentiation and cease to express these carbohy-
drate markers but now express the CS-sulfation motifs 4-C-3,
7-D-4, and 3-B-3(−). These sulfation motifs have yet to be spe-
ciﬁcally demonstrated as GAG components of podocalyxcin;
however the importance of CS as an essential component in
the attainment of stem cell pluripotency is well-established.
Therefore, the CS-sulfation motifs usefully identify the acti-
vated stem cell phenotype during tissue morphogenesis. Anti-
bodies that identify these speciﬁc CS sulfation motifs are
therefore useful research tools, which can be used to monitor
the phenotypic status of stem cells in developmental tissues.
Human embryonic stem cells display a characteristic N-
glycome consisting of a constant part and a variable portion
that change during differentiation [73]. Murine embryonic stem
cells display complex fucosylation patterns in cell surface glyco-
proteins previously identiﬁed by SSEA-1 antibody, complex
fucosylation is also a characteristic glycosylation feature in
undifferentiated hESC. The complexity of cell surface glycosyla-
tion patterns in the N-glycome of human embryonic stem cells
has been determined using matrix-assisted laser desorption/
ionization time-of ﬂight (MALDI-TOF) mass spectrometric and
NMR spectroscopic proﬁling [73]. Lewis X antigen (Le X) is an
abundant component of these sialylated complex-type N-
glycans and has been used previously as a marker of embryonic
stem cells and multipotential cells of early embryos. Le X is
expressed in human and murine neural stem cells [74]. SSEA-1
is also expressed speciﬁcally by developing sensory neuroblasts.
Murine SSEA-1 [75] is a carbohydrate differentiation antigen of
the basic structure β13 fucosyl N acetyllactosamine [Galβ1-4
(Fucα 13)GlcNAc [15] appearing at the late 8-cell stage of the
mouse embryo [76].
Figure 5. FGF-18 promotes early chondrogenesis and matura-
tional osteogenic differentiation of ovine stromal stem cells grown
in micromass pellet culture. (D), (E): Decorin and biglycan were
strongly upregulated by FGF-18 on days 31–41. The CS sulfation
motifs 4-C-3 and 7-D-4 (G), (H) followed a similar deposition to that
of calcium in the pellets evident by Alizaran staining (I).
Figure modiﬁed from [40] with permission. Histograms depict
RTPCR data showing the increase in decorin and biglycan expres-
sion with FGF-18 treatment (J), and densitometric morphological
data depicting Calcium deposition levels in pellets (K). Immunoloca-
lization of 3-B-3(−), 7-D-4, and 4-C-3 CS sulfation motifs in transi-
tional tissues in fetal knee joint development in a 14 –week-old
gestational age human fetal knee. 3-B-3(−), 7-D-4, and 4-C-3 were
immunolocalized in the rudiment tibial surface, perichondrium, and
tibial growth plate. Figure modiﬁed from [41] with permission.
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Application of Mass Spectrometry and Proteomics for
the Characterization of Stem Cell Populations Through
Their Expression Proﬁles of Cell Surface Proteins
Mass spectrometry (MS) and proteomics are powerful tech-
niques for the comparative analysis of cellular protein expres-
sion proﬁles. Global approaches have been used to deﬁne the
MSC proteome [77,78] and to track differentiation dependent
changes in membrane protein expression [79]. Previously, com-
prehensive identiﬁcation of speciﬁc MSC surface markers has
been limited by a lack of enrichment of membrane proteins,
insufﬁcient resolution of peptides prior to MS, and inability to
compare protein levels between progenitor and differentiated
cell populations. The cell surface associated proteins (the sur-
faceome) of human bone marrow MSCs, human umbilical cord
perivascular stem cells (HUCPVCs), and adult mesenchymal
ﬁbroblasts has now been undertaken in combination with sub-
cellular protein fractionation and eight channel isobaric tagging
of proteins for relative and absolute quantiﬁcation (iTRAQ) to
compare the proteomes of bone marrow MSCs and HUCPVCs
[61]. This identiﬁed 186 signiﬁcantly enriched proteins in multi-
ple cultures of MSCs and HUCPVCs compared with adult
human dermal ﬁbroblasts, and 216 proteins that were signiﬁ-
cantly downregulated. Cell-type-speciﬁc protein differences
were also quantiﬁed. These data have allowed the construc-
tion of a protein proﬁle repository database that enables
improved selection and characterization of human mesenchy-
mal progenitor cell populations.
Identiﬁcation of Roles for MSCs in Tissue
Morphogenesis
Although mesenchymal stem/stromal cells (MSCs) are recog-
nized as important components of the hematopoietic niche a
lack of speciﬁc markers of the activated MSC phenotype has
hindered the full characterization of the roles of these cells in
tissue development. The subsequent identiﬁcation of MSC
markers such as the leptin receptor (LepR), a receptor for a fat
cell-speciﬁc hormone has been applied to fate mapping stud-
ies, which have facilitated the identiﬁcation of speciﬁc MSC
populations with roles in tissue morphogenesis and connective
tissue remodeling [80]. LepR+ cells appear postnatally in the
bone marrow and are a major source of new osteoblasts and
adipocytes [60]. Leptin regulates bone formation [81] through
differential ALK1 and ALK5 signaling by MSCs [82] regulating
chondrocyte differentiation and ECM maturation during endo-
chondral ossiﬁcation [83]. Leptin also increases growth of the
primary ossiﬁcation centers in fetal mice [84].
Immunohistochemistry of fetal cartilage tissue sections for
Gremlin-1(GREM1) and bone γ-carboxyglutamic acid-
containing protein (BGLAP) demonstrates differential expres-
sion of these prominent MSC genes by articular chondrocytes
and osteophytic chondrocytes and bone, respectively. Gremlin-
1 identiﬁes skeletal stem cells with bone, cartilage, and reticu-
lar stromal potential [59] and is a key regulator of human artic-
ular cartilage homeostasis [85]. GREM-1 is a BMP antagonist
that inhibits BMP2 and BMP4 and the TGF-β signaling pathway
during limb bud cartilage development and acts in a co-
ordinated fashion with the upregulation in FGF4 and FGF8 and
SHH signaling, which occurs in cartilage development. BGLAP
(osteocalcin) is a noncollagenous pro-osteoblastic hormone,
which promotes bone formation in fetal tissues.
OX-2 glycoprotein (CD200) is a type I transmembrane gly-
coprotein member of the immunoglobulin superfamily, which
is expressed on the cell surface of some bone marrow MSCs.
Screening of human and murine bone marrow derived stem
cells for cell surface markers has identiﬁed CD200 as a marker
for MSCs with osteogenic potential [86] and that CD200+ MSCs
are committed along a differentiation pathway toward an oste-
oblastic lineage [87].
Nestin (acronym for neuroectodermal stem cell marker) is a
240 kDa type VI intermediate ﬁlament protein which is tran-
siently expressed during development and determines the
shapes of cells through the formation of cytoskeletal microtu-
bules [88]. Nestin expression disappears with MSC differentiation
and it is not detectable in adult tissues. Nestin is expressed by
bone marrow MSCs [89]. Interestingly, TGF-β activates nestin-
positive MSCs to become cell clusters and inactivation of this sig-
naling pathway reduces osteoarthritic changes in articular carti-
lage [90]. Inhibition of TGF-β expression by MSCs in subchondral
bone attenuates OA development [90].
The identiﬁcation of 4-C-3, 7-D-4, and 3-B-3(−) expression
by joint morphogenetic cells [57] complements the aforemen-
tioned MSC markers and is a useful means of identifying a
shift in cell surface marker expression in MSCs ,which have
become activated and have now developed migratory proper-
ties thus can participate in tissue development and tissue mor-
phogenesis in areas distant from the stem cell niche.
Immunolocalization of the 4-C-3 and 7-D-4 CS sulfation
Motifs Identify Chondroprogenitor Cells and
Transitional Tissues Undergoing Morphogenetic Change
in Foetal Joint Development Proteoglycans
The 4-C-3 and 7-D-4 CS sulfation motifs immunolocate areas of
tissue undergoing morphogenesis, progenitor cells and stem cell
niches in the stromal tissues adjacent to the cartilage rudiment
margins and in the superﬁcial cartilage of the articular surface
zones and in the perichondrium of developing joints [16,35]. The
CS sulfation motifs were also seen distally in the terminally dif-
ferentiated chondrocytes of the tibial fetal growth plate in areas
of cartilage calciﬁcation (Fig. 5O–5Q). Areas of the perichon-
drium were also prominently stained for the CS sulfation motifs,
and areas of vascular ingrowth into the cartilage rudiments a
few cartilage canals also were prominently stained with the
3-B-3(−), 7-D-4, and 4-C-3 epitopes (Fig. 5L–5N). Confocal studies
on the human fetal elbow also identiﬁed prominently stained
cell populations in the perichondrium and surface regions of the
developing joint interzone (Fig. 3). Perlecan was prominently
expressed pericellularly by somewhat ﬂattened cells in the outer
ﬁbrous regions of the perichondrium, whereas a more rounded
cell population was evident further from the rudiment surface,
which had very prominent pericellular staining for the 4C3 and
7D4 CS sulfation motifs (Fig. 3D, 3F). These cells were also prom-
inent in the surface areas of the interzone region of the develop-
ing elbow joint where the 4C3 epitope was prominently
localized pericellularly [27].
Focal Expression of CS Sulfation Motifs Identiﬁes Stem
Cells on the Luminal Surfaces of Foetal Blood Vessels
in Close Proximity to Pericytes a Progenitor Cell Type
for Vascular Stem Cell Development
Endothelial cells express the HS-proteoglycan perlecan, which is a
major component of vascular basement membranes. Endothelial
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cells focally express perlecan substituted with the 7-D-4 CS sulfa-
tion motif on the lumenal surface of small paraspinal blood ves-
sels in developmental human fetal spinal tissues (Fig. 2J) [44]. In
mature vessels, endothelial cells normally express a monosubsti-
tuted HS-perlecan; however, smooth muscle cells and chondro-
cytes express a hybrid form of perlecan containing CS and HS
chains. The presence of 7-D-4 substituted perlecan in microvessels
provides further evidence of a vessel associated progenitor cell
population and a vascular stem cell niche further adding to the
complexity of stem cell biology.
Pericytes are embedded in basement membrane where
they communicate directly with endothelial cells in the smal-
lest blood vessels, paracrine signaling also regulates interac-
tions between pericytes and endothelial cells . Caplan [91]
reiterated proposals made earlier by Canﬁeld and colleagues
[92–94]that pericytes had importance as a progenitor stem cell
type, emphasized their perivascular origin and ubiquitous dis-
tribution in tissues throughout the human body. Pericytes have
important multifunctional roles to play in the mobilization of
vascular stem cells during tissue injury and also in develop-
mental processes [95,96] and may be of great therapeutic
potential [97]. This is consistent with the differentiation of cul-
tured pericytes into multiple cell types in vitro or following
transplantation [98]. However, a recent cell-lineage study
showed that perivascular cells do not behave as tissue-speciﬁc
progenitors in various organs, despite their ability to differenti-
ate into multiple cell types in-vitro questioning the dogma pro-
posed by Caplan that all stem cells are pericytes [99]. Pericytes
have roles in vascular calciﬁcation [92], display osteogenic
potential [94], participate in ectopic calciﬁcation [93], establish
the blood brain barrier, are sources of multipotent vascular
stem cells following ischemic stroke and constitute part of a
neurovascular unit required for brain development [97].
CONCLUSIONS
CS sulfation motifs are transient, focal entities that convey subtle
information to cell populations in a spatial and temporal manner,
which regulate cell behavior in transitional tissues undergoing
morphogenesis. Stem cells are normally protected in the niche
environment and maintained in an aggregated compact form by
cell surface proteins such as E-cadherin. Embryonic stem cells
when in a quiescent state also express carbohydrate cell surface
markers such as SSEA-1 , ECMA-1 and 2, TRA 1–60 and TRA-1-81,
and GCTM-2, these are components of large CS and KS
substituted cell surface proteoglycans [71,72]. When stem cells
become activated and undergo differentiation they no longer
express these markers and express many of the CS-sulfation
motifs outlined in this study, such as 4-C-3, 7-D-4, and 3-B-3(−). A
shift from E-cadherin expression to N-cadherin is also evident.
These changes are considered important in the attainment of
pluripotency and CS has essential roles to play in these processes.
The CS-sulfation motifs are useful markers to identify the acti-
vated stem cell phenotype in tissue development involving pro-
genitor cell populations. The antibodies raised to the CS sulfation
motifs described herein are therefore useful research tools to
monitor such processes.
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